Axsome Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.

About AXSM

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. 

CEO
Herriott Tabuteau
CEOHerriott Tabuteau
Employees
683
Employees683
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2012
Founded2012
Employees
683
Employees683

AXSM Key Statistics

Market cap
5.19B
Market cap5.19B
Price-Earnings ratio
-18.28
Price-Earnings ratio-18.28
Dividend yield
—
Dividend yield—
Average volume
629.17K
Average volume629.17K
High today
$106.62
High today$106.62
Low today
$103.96
Low today$103.96
Open price
$104.82
Open price$104.82
Volume
245.09K
Volume245.09K
52 Week high
$139.13
52 Week high$139.13
52 Week low
$72.21
52 Week low$72.21

Analyst ratings

100%

of 19 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own AXSM. This list is generated using Robinhood data, and it’s not a recommendation.
Viking Therapeutics
Alibaba
Moderna
Eli Lilly
Pfizer
CRISPR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.